An Observational Drug Utilization Study of SYCREST® (asenapine) in the United Kingdom (P08308)

31/05/2017
02/07/2024
EU PAS number:
EUPAS17681
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

8274-108+Protocol+AM3_final-redaction

English (304.77 KB - PDF) View document
Study results
Study results

MK-8274-108_final-report_NoAppendices_final-redaction

English (2.2 MB - PDF) View document
Study report
Other information